Citations (117)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Prem Chandra & Devendra Pratap Singh. (2023) Sources, purification, immobilization and industrial applications of microbial lipases: An overview. Critical Reviews in Food Science and Nutrition 63:24, pages 6653-6686.
Read now
Read now
Benjamin Crulli, Alison M. Dines, Georgina Blanco, Isabelle Giraudon, Florian Eyer, Matthias E. Liechti, Òscar Miró, Knut E. Hovda, Fridtjof Heyerdahl, Christopher Yates, Odd Martin Vallersnes, David M. Wood, Paul I. Dargan, Lukasz Anand, Kurt Anseeuw, Robertas Badaras, Jeffrey Bonnici, Miran Brvar, Blazena Caganova, Feriyde Calýskan, Alessandro Ceschi, Karam Chamoun, Laurence Daveloose, Miguel Galicia, Stefanie Geith, Ketevan Gorozia, Damjan Grenc, Femke Gresnigt, Laura Hondebrink, Gesche Jürgens, Jutta Konstari, Soso Kutubidze, Gabija Laubner, Evangelia Liakoni, Viesturs Liguts, Cathelijne Lyphout, Thomas MacMahon, Bruno Mégarbane, Adrian Moughty, Gabriela Viorela Nitescu, Roberta Noseda, Niall O'Connor, Raido Paasma, Juan Ortega Perez, Marius Perminas, Per Sverre Persett, Kristiina Põld, Jordi Puiguriguer, Julia Radenkova-Saeva, Jan Rulisek, Yasmin Schmid, Irene Scholz, Roberts Stašinskis, Jonas Surkus, Wesley van den Busken, Irma van den Hengel-Koot, Federico Vigorita, Wojciech Waldmanm, William Stephen Waring & Sergej Zacharov. (2022) Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–2019. Clinical Toxicology 60:12, pages 1318-1327.
Read now
Read now
Chris Bulmer & Adam Balen. (2021) Illicit drug use and fertility treatment: should we be developing a standard operating procedure?. Human Fertility 24:5, pages 316-324.
Read now
Read now
. (2015) XXXV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 26–29 May 2015, St Julian's, Malta. Clinical Toxicology 53:4, pages 233-403.
Read now
Read now
Matilda Bäckberg, Erik Lindeman, Olof Beck & Anders Helander. (2015) Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clinical Toxicology 53:1, pages 46-53.
Read now
Read now
Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon, Christopher Yates, Alison M. Dines, Roumen Sedefov, David M. Wood & Paul I. Dargan. (2014) Current European data collection on emergency department presentations with acute recreational drug toxicity: Gaps and national variations. Clinical Toxicology 52:10, pages 1005-1012.
Read now
Read now
P. I. Dargan, H. C. Tang, W. Liang, D. M. Wood & D. T. Yew. (2014) Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice. Clinical Toxicology 52:3, pages 176-180.
Read now
Read now
David Michael Wood & Paul Ivor Dargan. (2014) Using Internet Snapshot Surveys to Enhance Our Understanding of the Availability of the Novel Psychoactive Substance Alpha-methyltryptamine (AMT). Substance Use & Misuse 49:1-2, pages 7-12.
Read now
Read now
Anders Helander, Olof Beck, Robert Hägerkvist & Peter Hultén. (2013) Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project. Scandinavian Journal of Clinical and Laboratory Investigation 73:5, pages 400-406.
Read now
Read now
Anette Kjellgren & Kristoffer Jonsson. (2013) Methoxetamine (MXE) – A Phenomenological Study of Experiences Induced by a “Legal High” from the Internet. Journal of Psychoactive Drugs 45:3, pages 276-286.
Read now
Read now
S. Rutherfoord Rose, Justin L. Poklis & Alphonse Poklis. (2013) A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Clinical Toxicology 51:3, pages 174-177.
Read now
Read now
Jennifer E. Shields, Paul I. Dargan, David M. Wood, Malgorzata Puchnarewicz, Susannah Davies & W. Stephen Waring. (2012) Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation. Clinical Toxicology 50:5, pages 438-440.
Read now
Read now
Articles from other publishers (105)
Jeanna M. Marraffa. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
993
996
.
Miroslava Bursová, Tomáš Hložek, Miloš Sokol, Monika Židková & Radomír Čabala. (2023) Methoxetamine and its metabolites: Postmortem determination in body fluids of human cadaver. Journal of Analytical Toxicology.
Crossref
Crossref
Jiang Ling, Wenqi Zhang, Xiaojun Yan, Wenlong Liu, Yanyan Wang & Yanjun Ding. (2022) Sensitive detection and primary metabolism analysis of flualprazolam in blood. Journal of Forensic and Legal Medicine 90, pages 102388.
Crossref
Crossref
Shaun L. Greene. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
495
532
.
Kerry Layne, Paul I. Dargan & David M. Wood. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
333
380
.
Michał Bujalski, Łukasz Wieczorek & Janusz Sierosławski. (2021) Risk perception and risk aversion among people who use New Psychoactive Substances. International Journal of Drug Policy 97, pages 103326.
Crossref
Crossref
Darlene Mae Ortiz, Raly James Perez Custodio, Arvie Abiero, Chrislean Jun Botanas, Leandro Val Sayson, Mikyung Kim, Hyun Jun Lee, Hee Jin Kim, Youngdo Jeong, Sulmin Yoon, Yong Sup Lee & Jae Hoon Cheong. (2020) The dopaminergic alterations induced by 4‐F‐PCP and 4‐Keto‐PCP may enhance their drug‐induced rewarding and reinforcing effects: Implications for abuse. Addiction Biology 26:4.
Crossref
Crossref
Emanuele Amorim Alves. (2020) DARK Classics in Chemical Neuroscience: Krokodil. ACS Chemical Neuroscience 11:23, pages 3968-3978.
Crossref
Crossref
Y. Moutaouakkil, F. Zahrae Loukili, M. Ait Elcadi, Y. Cherrah, Y. Bousliman & R. El Jaoudi. (2020) Toxicologie des Cathinones « Sels de bain ». Journal Européen des Urgences et de Réanimation 32:4, pages 142-150.
Crossref
Crossref
Jordan L. Tanen, Ira S. Lurie & Ioan Marginean. (2020) Gas chromatography with dual cold electron ionization mass spectrometry and vacuum ultraviolet detection for the analysis of phenylethylamine analogues. Forensic Chemistry 21, pages 100281.
Crossref
Crossref
J. Eichler, M. Rehm & S. C. Azad. (2020) „Legal Highs“ (neue psychoaktive Substanzen)“Legal highs” (new psychoactive substances). Der Anaesthesist 69:8, pages 599-608.
Crossref
Crossref
Barbara Loi, Michelle A. Sahai, Maria Antonietta De Luca, Hana Shiref & Jolanta Opacka-Juffry. (2020) The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)—Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP). Frontiers in Pharmacology 11.
Crossref
Crossref
Arvie Abiero, In Soo Ryu, Chrislean Jun Botanas, Raly James Perez Custodio, Leandro Val Sayson, Mikyung Kim, Hyun Jun Lee, Hee Jin Kim, Joung-Wook Seo, Min Chang Cho, Kun Won Lee, Sung Yeun Yoo, Choon-Gon Jang, Yong Sup Lee & Jae Hoon Cheong. (2020) Four Novel Synthetic Tryptamine Analogs Induce Head-Twitch Responses and Increase 5-HTR2a in the Prefrontal Cortex in Mice. Biomolecules & Therapeutics 28:1, pages 83-91.
Crossref
Crossref
Bruna de Souza Boff, Jair Silveira Filho, Karina Nonemacher, Samilla Driessen Schroeder, Marcelo Dutra Arbo & Kéttulin Zomer Rezin. (2020) New psychoactive substances (NPS) prevalence over LSD in blotter seized in State of Santa Catarina, Brazil: A six-year retrospective study. Forensic Science International 306, pages 110002.
Crossref
Crossref
M. Rosaria Varì, Simona Pichini, Raffaele Giorgetti & Francesco P. Busardò. (2018) New psychoactive substances—Synthetic stimulants. WIREs Forensic Science 1:2.
Crossref
Crossref
Kayla A. Nichols & Christopher A. Paciullo. (2019) Subdissociative Ketamine Use in the Emergency Department. Advanced Emergency Nursing Journal 41:1, pages 15-22.
Crossref
Crossref
Elaine Fehrman, Vincent Egan, Alexander N. Gorban, Jeremy Levesley, Evgeny M. Mirkes & Awaz K. MuhammadElaine Fehrman, Vincent Egan, Alexander N. Gorban, Jeremy Levesley, Evgeny M. Mirkes & Awaz K. Muhammad. 2019. Personality Traits and Drug Consumption. Personality Traits and Drug Consumption
129
130
.
Pia Simona Bruni, Katharina Elisabeth Grafinger, Susanne Nussbaumer, Stefan König, Stefan Schürch & Wolfgang Weinmann. (2018) Study of the in vitro and in vivo metabolism of 4-HO-MET. Forensic Science International 290, pages 103-110.
Crossref
Crossref
Joshua Z. Seither, Ralph Hindle, Luis E. Arroyo-Mora & Anthony P. DeCaprio. (2018) Systematic analysis of novel psychoactive substances. I. Development of a compound database and HRMS spectral library. Forensic Chemistry 9, pages 12-20.
Crossref
Crossref
Katharina Elisabeth Grafinger, Marianne Hädener, Stefan König & Wolfgang Weinmann. (2018)
Study of the
in vitro
and
in vivo
metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples
. Drug Testing and Analysis 10:3, pages 562-574.
Crossref
Crossref
Nicola Bates. (2018) Exposure to drugs of abuse. Companion Animal 23:2, pages 73-80.
Crossref
Crossref
Christophe Soussan, Martin Andersson & Anette Kjellgren. (2018) The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives. International Journal of Drug Policy 52, pages 71-78.
Crossref
Crossref
C. A. Y. Wayhs, M. Reis, K. C. Mariotti, W. Romão, B. G. Vaz, F. Barreto, R. S. Ortiz & R. P. Limberger. (2018) NBOMe Designer Drugs: GC-MS and LC-QTOF/MS Detection on Blotter Paper by Brazilian Federal Police (Rio Grande do Sul, Brazil). Brazilian Journal of Forensic Sciences, Medical Law and Bioethics 7:3, pages 193-204.
Crossref
Crossref
Daniel Pasin, Adam Cawley, Sergei Bidny & Shanlin Fu. (2017) Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review. Analytical and Bioanalytical Chemistry 409:25, pages 5821-5836.
Crossref
Crossref
D. Fabregat-Safont, M. Barneo-Muñoz, F. Martinez-Garcia, J.V. Sancho, F. Hernández & M. Ibáñez. (2017) Proposal of 5-methoxy- N -methyl- N -isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice. Journal of Chromatography A 1508, pages 95-105.
Crossref
Crossref
Sulaf Assi, Nargilya Gulyamova, Paul Kneller & David Osselton. (2017) The effects and toxicity of cathinones from the users' perspectives: A qualitative study. Human Psychopharmacology: Clinical and Experimental 32:3, pages e2610.
Crossref
Crossref
Diego Hernando Ângulo Florez, Ana Maria dos Santos Moreira, Pedro Rafael da Silva, Ricardo Brandão, Marcella Matos Cordeiro Borges, Fernando José Malagueño de Santana & Keyller Bastos Borges. (2017) Desomorphine (Krokodil): An overview of its chemistry, pharmacology, metabolism, toxicology and analysis. Drug and Alcohol Dependence 173, pages 59-68.
Crossref
Crossref
Timothy Fassette & Afton Martinez. (2016) An Impaired Driver Found to be Under the Influence of Methoxetamine. Journal of Analytical Toxicology 40:8, pages 700-702.
Crossref
Crossref
Katrina E. Champion, Nicola C. Newton, Lexine A. Stapinski & Maree Teesson. (2016) Effectiveness of a universal internet-based prevention program for ecstasy and new psychoactive substances: a cluster randomized controlled trial. Addiction 111:8, pages 1396-1405.
Crossref
Crossref
Honggang Nie, Xianjiang Li, Zhendong Hua, Wei Pan, Yanping Bai & Xiaofang Fu. (2016) Rapid screening and determination of 11 new psychoactive substances by direct analysis in real time mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry 30, pages 141-146.
Crossref
Crossref
Jollee J. Daniel & Robert N. Hughes. (2016) Increased anxiety and impaired spatial memory in young adult rats following adolescent exposure to methylone. Pharmacology Biochemistry and Behavior 146-147, pages 44-49.
Crossref
Crossref
R. Risoluti, S. Materazzi, A. Gregori & L. Ripani. (2016) Early detection of emerging street drugs by near infrared spectroscopy and chemometrics. Talanta 153, pages 407-413.
Crossref
Crossref
Christophe Soussan & Anette Kjellgren. (2016) The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations. International Journal of Drug Policy 32, pages 77-84.
Crossref
Crossref
Jack L Stanley, Daniel V Mogford, Rebecca J Lawrence & Stephen M Lawrie. (2016) Use of novel psychoactive substances by inpatients on general adult psychiatric wards. BMJ Open 6:5, pages e009430.
Crossref
Crossref
Katrina E. Champion, Maree Teesson & Nicola C. Newton. (2016) Patterns and correlates of new psychoactive substance use in a sample of Australian high school students. Drug and Alcohol Review 35:3, pages 338-344.
Crossref
Crossref
Adam R. Winstock, Will Lawn, Paolo Deluca & Rohan Borschmann. (2016) Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample. Drug and Alcohol Review 35:2, pages 212-217.
Crossref
Crossref
Yacine Boumrah, Luc Humbert, Melodie Phanithavong, Kamel Khimeche, Abdallah Dahmani & Delphine Allorge. (2016)
In vitro
characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS
. Drug Testing and Analysis 8:2, pages 248-256.
Crossref
Crossref
Steve Johnston. (2016) Plan for quality improvement: the ‘Legal High’ Guide. Journal of Paramedic Practice 8:1, pages 36-40.
Crossref
Crossref
Colin Davidson & Fabrizio Schifano. (2016) The potential utility of some legal highs in CNS disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 267-274.
Crossref
Crossref
Ivan Senta, Ivona Krizman, Marijan Ahel & Senka Terzic. (2015) Multiresidual analysis of emerging amphetamine-like psychoactive substances in wastewater and river water. Journal of Chromatography A 1425, pages 204-212.
Crossref
Crossref
S. Gibbons. (2015) Novel psychoactive substances: A chemical overview for the toxicologist. Toxicology Letters 238:2, pages S4.
Crossref
Crossref
James H. Ho, George P. Bailey, John R. H. Archer, Paul I. Dargan & David M. Wood. (2015) Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance. European Journal of Clinical Pharmacology 71:10, pages 1185-1196.
Crossref
Crossref
Kathleen S Bonnici, Paul I Dargan & David M Wood. (2015) Novel psychoactive substances or ‘legal highs'. British Journal of Hospital Medicine 76:9, pages C130-C134.
Crossref
Crossref
Ana Margarida Araújo, Félix Carvalho, Maria de Lourdes Bastos, Paula Guedes de Pinho & Márcia Carvalho. (2015) The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology 89:8, pages 1151-1173.
Crossref
Crossref
José Coelho Neto. (2015) Rapid detection of NBOME's and other NPS on blotter papers by direct ATR-FTIR spectrometry. Forensic Science International 252, pages 87-92.
Crossref
Crossref
Suzanne Fergus, Kathryn Kellett & Ute Gerhard. (2014) The Khat and Meow Meow Tale: Teaching the Relevance of Chemistry through Novel Recreational Drugs. Journal of Chemical Education 92:5, pages 843-848.
Crossref
Crossref
Laurent Karila, Bruno Megarbane, Lucie Chevillard, Nadia Benturquia, Jean-Louis Laplanche & Michel Lejoyeux. (2015) Nouveaux produits de synthèse : revue des données actuelles. La Presse Médicale 44:4, pages 383-391.
Crossref
Crossref
Markus R. Meyer, Lea Wagmann, Nicole Schneider-Daum, Brigitta Loretz, Cristiane de Souza Carvalho, Claus-Michael Lehr & Hans H. Maurer. (2015) P-glycoprotein interactions of novel psychoactive substances – Stimulation of ATP consumption and transport across Caco-2 monolayers. Biochemical Pharmacology 94:3, pages 220-226.
Crossref
Crossref
Hisham Nizar, Paul I. Dargan & David M. Wood. (2014) Using Internet Snapshot Surveys to Enhance Our Understanding of the Availability of the Novel Psychoactive Substance 4-Methylaminorex and 4,4′-Dimethylaminorex. Journal of Medical Toxicology 11:1, pages 80-84.
Crossref
Crossref
Adarsh S. Gandhi, Ariane Wohlfarth, Mingshe Zhu, Shaokun Pang, Marisol Castaneto, Karl B. Scheidweiler & Marilyn A. Huestis. (2015) High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liv. Drug Testing and Analysis 7:3, pages 187-198.
Crossref
Crossref
Katrina E. Champion, Maree Teesson & Nicola C. Newton. (2015) Development of a Universal Internet-Based Prevention Program for Ecstasy and New Psychoactive Substances. Open Journal of Preventive Medicine 05:01, pages 23-30.
Crossref
Crossref
Christophe SoussanAnette Kjellgren. (2015) “Chasing the High” – Experiences of Ethylphenidate as Described on International Internet Forums. Substance Abuse: Research and Treatment 9, pages SART.S22495.
Crossref
Crossref
Justin L. Poklis, Carl E. Wolf, Omar I. ElJordi, Kai Liu, Shijun Zhang & Alphonse Poklis. (2015) Analysis of the First- and Second-Generation Raving Dragon Novelty Bath Salts Containing Methylone and Pentedrone. Journal of Forensic Sciences 60, pages S234-S240.
Crossref
Crossref
Elena Durán, Marta Mosquera, Cristina Ruiz, Fernando Bandrés, Francesc Campos, Bartomeu Castanyer, Carme Farré, Juan Fernando Izquierdo, Elena Llorente, Jordi To-Figueras, Salvador Ventura & Josep M. Queraltó. (2015) Desoxipipradrol. Fármacos antiguos, problemas nuevos. Revista del Laboratorio Clínico 8:1, pages 29-38.
Crossref
Crossref
Jolanta B. Zawilska. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse
273
300
.
Atbin Djamshidian. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse
161
177
.
Golo M. J. Meyer, Carina S. D. Wink, Josef Zapp & Hans H. Maurer. (2014) GC-MS, LC-MSn, LC-high resolution-MSn, and NMR studies on the metabolism and toxicological detection of mesembrine and mesembrenone, the main alkaloids of the legal high “Kanna” isolated from Sceletium tortuosum. Analytical and Bioanalytical Chemistry 407:3, pages 761-778.
Crossref
Crossref
Kennerly S. Patrick, Timothy R. Corbin & Cristina E. Murphy. (2014) Ethylphenidate as a Selective Dopaminergic Agonist and Methylphenidate–Ethanol Transesterification Biomarker. Journal of Pharmaceutical Sciences 103:12, pages 3834-3842.
Crossref
Crossref
Magdalena Taschwer, Jennifer A. Weiß, Olaf Kunert & Martin G. Schmid. (2014) Analysis and characterization of the novel psychoactive drug 4-chloromethcathinone (clephedrone). Forensic Science International 244, pages e56-e59.
Crossref
Crossref
Ritva Karinen, Silja Skogstad Tuv, Sidsel Rogde, Mariana Dadalto Peres, Unni Johansen, Joachim Frost, Vigdis Vindenes & Åse Marit Leere Øiestad. (2014) Lethal poisonings with AH-7921 in combination with other substances. Forensic Science International 244, pages e21-e24.
Crossref
Crossref
Magdalene H.Y. Tang, C.K. Ching, Caroline Y.W. Lee, Ying-Hoo Lam & Tony W.L. Mak. (2014) Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by UHPLC-MS/MS. Journal of Chromatography B 969, pages 272-284.
Crossref
Crossref
Simon Elliott & Julie Evans. (2014) A 3-year review of new psychoactive substances in casework. Forensic Science International 243, pages 55-60.
Crossref
Crossref
Anders Helander, Matilda Bäckberg, Peter Hultén, Yasir Al-Saffar & Olof Beck. (2014) Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project. Forensic Science International 243, pages 23-29.
Crossref
Crossref
Sebastian Leth-Petersen, Christoffer Bundgaard, Martin Hansen, Martin A. Carnerup, Jan Kehler & Jesper Langgaard Kristensen. (2014) Correlating the Metabolic Stability of Psychedelic 5-HT2A Agonists with Anecdotal Reports of Human Oral Bioavailability. Neurochemical Research 39:10, pages 2018-2023.
Crossref
Crossref
Caroline Sastre, Cédric Mazoyer, Charlotte Mayer, Jérôme Grosjean, Vincent Di Fazio & Élodie Saussereau. (2014) Les cathinones : qu’en sait-on aujourd’hui ?. Toxicologie Analytique et Clinique 26:3, pages 148-155.
Crossref
Crossref
D. M. Wood, S. L. Hill, S. H. L. Thomas & P. I. Dargan. (2014) Using poisons information service data to assess the acute harms associated with novel psychoactive substances. Drug Testing and Analysis 6:7-8, pages 850-860.
Crossref
Crossref
Andrew G. Leach. (2013) Predicting the activity and toxicity of new psychoactive substances: a pharmaceutical industry perspective. Drug Testing and Analysis 6:7-8, pages 739-745.
Crossref
Crossref
Justin L. Poklis, Carol R. Nanco, Michelle M. Troendle, Carl E. Wolf & Alphonse Poklis. (2014) Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Testing and Analysis 6:7-8, pages 764-769.
Crossref
Crossref
Lucas R. Watterson & M. Foster Olive. (2014) Synthetic Cathinones and Their Rewarding and Reinforcing Effects in Rodents. Advances in Neuroscience 2014, pages 1-9.
Crossref
Crossref
John C. M. Brust. (2014) Neurologic Complications of Illicit Drug Abuse. CONTINUUM: Lifelong Learning in Neurology 20, pages 642-656.
Crossref
Crossref
María Ibáñez, Juan V. Sancho, Lubertus Bijlsma, Alexander L.N. van Nuijs, Adrian Covaci & Félix Hernández. (2014) Comprehensive analytical strategies based on high-resolution time-of-flight mass spectrometry to identify new psychoactive substances. TrAC Trends in Analytical Chemistry 57, pages 107-117.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging drugs of abuse. Disease-a-Month 60:3, pages 110-132.
Crossref
Crossref
Ivan Casselman, Catherine J. Nock, Hans Wohlmuth, Robert P. Weatherby & Michael Heinrich. (2014) From local to global—Fifty years of research on Salvia divinorum. Journal of Ethnopharmacology 151:2, pages 768-783.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging Drugs of Abuse. Emergency Medicine Clinics of North America 32:1, pages 1-28.
Crossref
Crossref
Christophe Soussan & Anette Kjellgren. (2014) Harm reduction and knowledge exchange—a qualitative analysis of drug-related Internet discussion forums. Harm Reduction Journal 11:1, pages 25.
Crossref
Crossref
Rossella Gottardo, Daniela Sorio, Giacomo Musile, Elisa Trapani, Catia Seri, Giovanni Serpelloni & Franco Tagliaro. (2013) Screening for synthetic cannabinoids in hair by using LC-QTOF MS: A new and powerful approach to study the penetration of these new psychoactive substances in the population. Medicine, Science and the Law 54:1, pages 22-27.
Crossref
Crossref
Justin L. Poklis, Kelly G. Devers, Elise F. Arbefeville, Julia M. Pearson, Eric Houston & Alphonse Poklis. (2014) Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Science International 234, pages e14-e20.
Crossref
Crossref
J.M. Marraffa. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology
248
251
.
John S. Markowitz & Kennerly S. Patrick. (2013) Ethylphenidate: From biomarker to designer drug. Mental Health Clinician 3:6, pages 318-320.
Crossref
Crossref
Katrina E Champion, Maree Teesson & Nicola C Newton. (2013) A cluster randomised controlled trial of the Climate Schools: Ecstasy and Emerging Drugs Modulein Australian secondary schools: study protocol. BMC Public Health 13:1.
Crossref
Crossref
Akira Namera, Kyohei Konuma, Takeshi Saito, Shigenori Ota, Hiroshi Oikawa, Shota Miyazaki, Shumari Urabe, Hiroaki Shiraishi & Masataka Nagao. (2013) Simple segmental hair analysis for α-pyrrolidinophenone-type designer drugs by MonoSpin extraction for evaluation of abuse history. Journal of Chromatography B 942-943, pages 15-20.
Crossref
Crossref
Justin L. Poklis, Jezelle Charles, Carl E. Wolf & Alphonse Poklis. (2013) High‐performance liquid chromatography tandem mass spectrometry method for the determination of 2CC‐NBOMe and 25I‐NBOMe in human serum. Biomedical Chromatography 27:12, pages 1794-1800.
Crossref
Crossref
Dieter Müller & Herbert Desel. (2013) Common Causes of Poisoning. Deutsches Ärzteblatt international.
Crossref
Crossref
. 2013. Brain Disorders in Critical Illness. Brain Disorders in Critical Illness
329
418
.
L. N. Seetohul & D. J. Pounder. (2013) Four Fatalities Involving 5-IT. Journal of Analytical Toxicology 37:7, pages 447-451.
Crossref
Crossref
David Rampe & Arthur M. Brown. (2013) A history of the role of the hERG channel in cardiac risk assessment. Journal of Pharmacological and Toxicological Methods 68:1, pages 13-22.
Crossref
Crossref
Warunya Arunotayanun, Jeffrey W. Dalley, Xi-Ping Huang, Vincent Setola, Ric Treble, Leslie Iversen, Bryan L. Roth & Simon Gibbons. (2013) An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: Emerging ‘Novel Psychoactive Drugs’. Bioorganic & Medicinal Chemistry Letters 23:11, pages 3411-3415.
Crossref
Crossref
Donata Favretto, Jennifer P. Pascali & Franco Tagliaro. (2013) New challenges and innovation in forensic toxicology: Focus on the “New Psychoactive Substances”. Journal of Chromatography A 1287, pages 84-95.
Crossref
Crossref
M. Coppola & R. Mondola. (2013) 5-Iodo-2-aminoindan (5-IAI): Chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects. Toxicology Letters 218:1, pages 24-29.
Crossref
Crossref
Markus R. Meyer, Tina Orschiedt & Hans H. Maurer. (2013) Michaelis–Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein. Toxicology Letters 217:2, pages 137-142.
Crossref
Crossref
Markus R. Meyer, Sara Schmitt & Hans H. Maurer. (2013) Studies on the metabolism and detectability of the emerging drug of abuse diphenyl‐2‐pyrrolidinemethanol (D2PM) in rat urine using GC‐MS and LC‐HR‐MS/MS. Journal of Mass Spectrometry 48:2, pages 243-249.
Crossref
Crossref
Samuel Mabbott, Elon Correa, David P. Cowcher, J. William Allwood & Royston Goodacre. (2012) Optimization of Parameters for the Quantitative Surface-Enhanced Raman Scattering Detection of Mephedrone Using a Fractional Factorial Design and a Portable Raman Spectrometer. Analytical Chemistry 85:2, pages 923-931.
Crossref
Crossref
Savithiri Ratnapalan. (2013) Legal substances and their abuse: Legal highs. Journal of Paramedic Practice 5:1, pages 40-51.
Crossref
Crossref
G. T. C. Wong & M. G. Irwin. (2013) Poisoning with illicit substances: toxicology for the anaesthetist. Anaesthesia 68, pages 117-124.
Crossref
Crossref
Maria Wikström, Gunilla Thelander, Maria Dahlgren & Robert Kronstrand. (2013) An Accidental Fatal Intoxication with Methoxetamine. Journal of Analytical Toxicology 37:1, pages 43-46.
Crossref
Crossref
Emuri Abe, Florian Ricard, Philippe Charlier, Geoffroy de la Grandmaison & Jean-Claude Alvarez. (2013) Intoxication non létale par la Méthoxétamine : confirmation analytique à l’aide d’un système d’extraction en ligne Turboflow® couplé à de la LC/MS/MS. Annales de Toxicologie Analytique 25:1, pages 17-25.
Crossref
Crossref
J.C. Ballenger. (2013) ‘Legal Highs’ – novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Yearbook of Psychiatry and Applied Mental Health 2013, pages 416-417.
Crossref
Crossref
Shaun L. Greene. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
393
409
.
Shaun L. Greene. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
363
381
.
David M. Wood & Paul I. Dargan. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
211
231
.
Emuri Abe, Florian Ricard, François Darrouzain & Jean Claude Alvarez. (2012) An automated method for measurement of methoxetamine in human plasma by use of turbulent flow on-line extraction coupled with liquid chromatography and mass spectrometric detection. Analytical and Bioanalytical Chemistry 405:1, pages 239-245.
Crossref
Crossref
John M. Corkery, Emma Durkin, Simon Elliott, Fabrizio Schifano & A. Hamid Ghodse. (2012) The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): A brief review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 259-262.
Crossref
Crossref
Laura Lindsay & Marjorie Lee White. (2012) Herbal Marijuana Alternatives and Bath Salts—“Barely Legal” Toxic Highs. Clinical Pediatric Emergency Medicine 13:4, pages 283-291.
Crossref
Crossref
D. M. Wood & P. I. Dargan. (2012) Using Journal Review Articles to Increase the Dissemination of Keynote and Symposia Lectures at International Medical Congresses. Journal of Medical Toxicology 8:3, pages 250-251.
Crossref
Crossref
M. Coppola & R. Mondola. (2012) Research chemicals marketed as legal highs: The case of pipradrol derivatives. Toxicology Letters 212:1, pages 57-60.
Crossref
Crossref